The Effect of Xolair ® (Omalizumab) in Mastocytosis Patients
Clinical trial NCT01333293 · COMPLETED
Trial details
- NCT number
- NCT01333293
- Sponsor
- University of Zurich
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2015-10-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.